147 related articles for article (PubMed ID: 23098853)
1. Role of somatomedin-B-like domains on ENPP1 inhibition of insulin signaling.
Dimatteo C; Marucci A; Palazzo A; Cisternino C; Marsano RM; Trischitta V; Di Paola R
Biochim Biophys Acta; 2013 Mar; 1833(3):552-8. PubMed ID: 23098853
[TBL] [Abstract][Full Text] [Related]
2. Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling.
Marucci A; Cozzolino F; Dimatteo C; Monti M; Pucci P; Trischitta V; Di Paola R
Biochim Biophys Acta; 2013 Jun; 1833(6):1388-95. PubMed ID: 23500900
[TBL] [Abstract][Full Text] [Related]
3. In silico analysis of the two tandem somatomedin B domains of ENPP1 reveals hints on the homodimerization of the protein.
Bellacchio E
J Cell Physiol; 2012 Nov; 227(11):3566-74. PubMed ID: 22262087
[TBL] [Abstract][Full Text] [Related]
4. ENPP1 affects insulin action and secretion: evidences from in vitro studies.
Di Paola R; Caporarello N; Marucci A; Dimatteo C; Iadicicco C; Del Guerra S; Prudente S; Sudano D; Miele C; Parrino C; Piro S; Beguinot F; Marchetti P; Trischitta V; Frittitta L
PLoS One; 2011 May; 6(5):e19462. PubMed ID: 21573217
[TBL] [Abstract][Full Text] [Related]
5. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858
[TBL] [Abstract][Full Text] [Related]
6. The role of HSP70 on ENPP1 expression and insulin-receptor activation.
Marucci A; Miscio G; Padovano L; Boonyasrisawat W; Florez JC; Doria A; Trischitta V; Paola RD
J Mol Med (Berl); 2009 Feb; 87(2):139-144. PubMed ID: 19083193
[TBL] [Abstract][Full Text] [Related]
7. Liver ENPP1 protein increases with remission of type 2 diabetes after gastric bypass surgery.
Besic V; Stubbs RS; Hayes MT
BMC Gastroenterol; 2014 Dec; 14():222. PubMed ID: 25539584
[TBL] [Abstract][Full Text] [Related]
8. The hepatic ectonucleotide pyrophosphatase/phosphodiesterase 1 gene mRNA abundance is reduced by insulin and induced by dexamethasone.
Ma H; Wang P; Jin D; Jia T; Mao H; Zhang J; Zhao S
Braz J Med Biol Res; 2018 Mar; 51(4):e6980. PubMed ID: 29513794
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells.
Caporarello N; Parrino C; Trischitta V; Frittitta L
PLoS One; 2017; 12(8):e0181190. PubMed ID: 28767692
[TBL] [Abstract][Full Text] [Related]
10. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo.
Zhou HH; Chin CN; Wu M; Ni W; Quan S; Liu F; Dallas-Yang Q; Ellsworth K; Ho T; Zhang A; Natasha T; Li J; Chapman K; Strohl W; Li C; Wang IM; Berger J; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Aug; 616(1-3):346-52. PubMed ID: 19577557
[TBL] [Abstract][Full Text] [Related]
11. Role of ENPP1 on adipocyte maturation.
Liang J; Fu M; Ciociola E; Chandalia M; Abate N
PLoS One; 2007 Sep; 2(9):e882. PubMed ID: 17849011
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
Dongiovanni P; Valenti L; Rametta R; Daly AK; Nobili V; Mozzi E; Leathart JB; Pietrobattista A; Burt AD; Maggioni M; Fracanzani AL; Lattuada E; Zappa MA; Roviaro G; Marchesini G; Day CP; Fargion S
Gut; 2010 Feb; 59(2):267-73. PubMed ID: 20176643
[TBL] [Abstract][Full Text] [Related]
13. Metabolic consequences of ENPP1 overexpression in adipose tissue.
Pan W; Ciociola E; Saraf M; Tumurbaatar B; Tuvdendorj D; Prasad S; Chandalia M; Abate N
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E901-11. PubMed ID: 21810932
[TBL] [Abstract][Full Text] [Related]
14. The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals.
Maranghi M; Prudente S; D'Erasmo L; Morini E; Ciociola E; Coletta P; Verrienti A; Arciello S; Copetti M; Pellegrini F; Santini SA; Morano S; Filetti S; Trischitta V
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):505-10. PubMed ID: 22402064
[TBL] [Abstract][Full Text] [Related]
15. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
[TBL] [Abstract][Full Text] [Related]
16. Crystallization of ectonucleotide phosphodiesterase/pyrophosphatase-3 and orientation of the SMB domains in the full-length ectodomain.
Döhler C; Zebisch M; Krinke D; Robitzki A; Sträter N
Acta Crystallogr F Struct Biol Commun; 2018 Nov; 74(Pt 11):696-703. PubMed ID: 30387774
[TBL] [Abstract][Full Text] [Related]
17. Cole Disease Results from Mutations in ENPP1.
Eytan O; Morice-Picard F; Sarig O; Ezzedine K; Isakov O; Li Q; Ishida-Yamamoto A; Shomron N; Goldsmith T; Fuchs-Telem D; Adir N; Uitto J; Orlow SJ; Taieb A; Sprecher E
Am J Hum Genet; 2013 Oct; 93(4):752-7. PubMed ID: 24075184
[TBL] [Abstract][Full Text] [Related]
18. ENPP1 gene, insulin resistance and related clinical outcomes.
Bacci S; De Cosmo S; Prudente S; Trischitta V
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Abate N; Chandalia M; Di Paola R; Foster DW; Grundy SM; Trischitta V
Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):694-701. PubMed ID: 17143316
[TBL] [Abstract][Full Text] [Related]
20. Hepatic ENPP1 expression is induced in diabetic rabbits.
Eller P; Hochegger K; Wehinger A; Tancevski I; Schgoer W; Ritsch A; Patsch JR
Mamm Genome; 2006 Aug; 17(8):886-91. PubMed ID: 16897338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
